- Home
- MTNB vs PRSO Comparison
MTNB vs PRSO Comparison
Compare MTNB & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- PRSO
- Stock Information
- Founded
- MTNB 2013
- PRSO 2008
- Country
- MTNB United States
- PRSO United States
- Employees
- MTNB N/A
- PRSO N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- MTNB Health Care
- PRSO Technology
- Exchange
- MTNB Nasdaq
- PRSO Nasdaq
- Market Cap
- MTNB 3.1M
- PRSO 3.3M
- IPO Year
- MTNB N/A
- PRSO 2001
- Fundamental
- Price
- MTNB $0.55
- PRSO $0.76
- Analyst Decision
- MTNB Hold
- PRSO Strong Buy
- Analyst Count
- MTNB 1
- PRSO 2
- Target Price
- MTNB N/A
- PRSO $3.38
- AVG Volume (30 Days)
- MTNB 285.7K
- PRSO 56.4K
- Earning Date
- MTNB 05-08-2025
- PRSO 05-12-2025
- Dividend Yield
- MTNB N/A
- PRSO N/A
- EPS Growth
- MTNB N/A
- PRSO N/A
- EPS
- MTNB N/A
- PRSO N/A
- Revenue
- MTNB N/A
- PRSO $12,728,000.00
- Revenue This Year
- MTNB N/A
- PRSO $9.59
- Revenue Next Year
- MTNB N/A
- PRSO $1.63
- P/E Ratio
- MTNB N/A
- PRSO N/A
- Revenue Growth
- MTNB N/A
- PRSO N/A
- 52 Week Low
- MTNB $0.48
- PRSO $0.73
- 52 Week High
- MTNB $21.50
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- MTNB 40.98
- PRSO 39.88
- Support Level
- MTNB $0.52
- PRSO $0.76
- Resistance Level
- MTNB $0.57
- PRSO $0.84
- Average True Range (ATR)
- MTNB 0.05
- PRSO 0.08
- MACD
- MTNB -0.00
- PRSO -0.00
- Stochastic Oscillator
- MTNB 9.95
- PRSO 8.99
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.